Latest: UTI Asset Management Company Ltd Q2 FY27 results →All Q4 FY26 results →
UA

UTI Asset Management Company Ltd

Q4 FY26Capital Markets

UTI Asset Management Company Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹893
Market cap₹11.7K Cr
P/E21.9
Updated23 Aug 2026
Read3 min read

The short version

Focus on growth driven by expanding retail participation, especially through SIPs targeting long-term flows. The company's single-line agenda is focused on growth, aiming to grow faster than peers in the Top 10 to benefit from operating leverage already built-in (Page 13). - Employee costs are expected to stabilize with quarterly run rates at Rs.

From UTI Asset Management Company Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Focus on growth driven by expanding retail participation, especially through SIPs targeting long-term flows.
  • Emphasis on broadening distribution, including metro, B30 cities, and emerging markets to capture larger market share.
  • Launching new passive funds (e.g., ETFs) aimed at lifecycle goals to attract diversified investors.
  • Investing significantly in technology and process improvements to boost sales efficiency and customer engagement.
  • Targeting increased new customer acquisition by tracking PANs and using digital platforms.
  • Empowering sales teams to promote multiple products, reducing reliance on a few flagship schemes.

2 more points from UTI Asset Management Company Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what UTI Asset Management Company Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The company does not plan any dramatic additions to the cash pile or capital investments at this time, aiming instead to maintain liquidity for potential future M&A opportunities.
  • Current profits are largely paid out as dividends, indicating a focus on returning cash to shareholders rather than building cash reserves or investing heavily in capex.
  • Investments are ongoing in technology and process improvements to boost efficiency and enable growth, especially in digital engagement and distribution.
  • There is a focus on broadening product offerings, including launching new passive funds and exploring the long short space in alternative investment products, though these are still in early stages.

Top-ranked in Capital Markets

Ranked on what management guided this quarter

Guidance-ranked
1BSE
Rev 2Mar 3
2Nippon Life Ind.
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what UTI Asset Management Company Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The discussion primarily revolves around mutual fund industry trends, investor behavior, SIP flows, distribution strategies, dividend policy, product pipeline, and financial performance.

UTI Asset Management Company Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹415 Cr, net profit ₹132 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Capital Markets this season

  • Emk.Global Fin. (Q4 FY26)

    Q4 FY26 Revenue from Operations: INR 1,484 million, up 109% YoY from INR 710 million in Q4 FY25 (Page 34). Key concall takeaways from Emkay Global Financial…

  • Systematix Corporate Services Ltd (Q4 FY26)

    Revenue from operations for Q4 FY26: ₹23.50 Cr . Key concall takeaways from Systematix Corporate Services Ltd's Q4 FY26 earnings call — and how it ranks…

  • Dam Capital Advisors Ltd (Q4 FY26)

    Quarterly Revenue (Q4 FY26):** ₹29.3 Cr vs. Key concall takeaways from Dam Capital Advisors Ltd's Q4 FY26 earnings call — and how it ranks against sector peers.

  • Indian Energy Ex (Q4 FY26)

    FY26 electricity volume rose 17% YoY to 141 billion units, with RTM volumes growing 41% and green market volumes up 23% YoY, indicating strong growth momentum…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

UTI Asset Management Company Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were UTI Asset Management Company Ltd Q4 FY26 results?

Focus on growth driven by expanding retail participation, especially through SIPs targeting long-term flows. The company's single-line agenda is focused on growth, aiming to grow faster than peers in the Top 10 to benefit from operating leverage already built-in (Page 13). - Employee costs are expected to stabilize with quarterly run rates at Rs.

What is UTI Asset Management Company Ltd share price analysis?

UTI Asset Management Company Ltd currently shows a neutral. The stock trades at a P/E of 21.9 with a market cap of ₹11,672 Cr. Investors should review the full earnings analysis for detailed insights.

Is UTI Asset Management Company Ltd planning capital expenditure?

The company does not plan any dramatic additions to the cash pile or capital investments at this time, aiming instead to maintain liquidity for potential future M&A opportunities.

Keep UTI Asset Management Company Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.